Infant-juvenile type 2 diabetes

M L Calero Bernal1, J M Varela Aguilar2

  • 1Servicio de Medicina Interna, Hospital San Juan de Dios del Aljarafe, Bormujos, Sevilla, España; Grupo de trabajo de Diabetes y Obesidad de SEMI, España.

Insights

Childhood type 2 diabetes mellitus (DM2) is rising with obesity. Early detection and management in at-risk youth are crucial to prevent long-term complications, as pediatric DM2 requires lifelong care.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Increasing prevalence of childhood obesity worldwide.
  • Parallel rise in type 2 diabetes mellitus (DM2) cases among children and adolescents.
  • Insulin resistance as a key factor in pediatric DM2 development.

Purpose of the Study:

  • To highlight the growing concern of type 2 diabetes mellitus in pediatric populations.
  • To emphasize the need for targeted screening in at-risk children.
  • To underscore the importance of managing comorbidities and long-term complications.

Main Methods:

  • Review of recent trends in childhood type 2 diabetes mellitus.
  • Analysis of the link between obesity and insulin resistance in youth.
  • Assessment of comorbidities associated with pediatric DM2 diagnosis.

Main Results:

  • Significant increase in type 2 diabetes mellitus cases in children and adolescents.
  • Obesity identified as a primary risk factor for pediatric DM2.
  • Comorbidities like hypertension and dyslipidemia are common in diagnosed children.

Conclusions:

  • Targeted screening for type 2 diabetes mellitus in overweight or obese children is recommended.
  • Comprehensive assessment and management of comorbidities are essential for preventing long-term complications.
  • Pediatric-onset type 2 diabetes mellitus necessitates lifelong management due to its prolonged duration.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
506